Seminars in Oncology
| 短名 | Semin. Oncol. |
| Journal Impact | 2.99 |
| 国际分区 | ONCOLOGY(Q2) |
| 期刊索引 | SCI Q2中科院 3 区 |
| ISSN | 0093-7754, 1532-8708 |
| h-index | 145 |
| 国内分区 | 医学(3区)医学肿瘤学(4区) |
肿瘤学研讨会为您提供有关癌症病因学、诊断和管理进展的最新、权威和实用的评论。每期都审查具有临床重要性的主题，重点是提供更好地理解某个主题所需的基本知识以及该领域领导者的循证意见。肿瘤学研讨会还寻求成为分享各种观点的场所，包括那些可能被认为是“开箱即用”的观点。我们欢迎以健康和尊重的方式交换意见，并敦促您向我们提出您的见解以及您认为值得报道的主题的建议。通过帮助读者了解基本生物学和癌症治疗，同时他们从专家那里了解细微差别，所有这些都在鼓励交流思想的期刊上，我们旨在帮助推动癌症治疗向前发展。
期刊主页投稿网址| 涉及主题 | 医学生物内科学遗传学癌症外科肿瘤科病理化疗化学免疫学生物化学癌症研究 |
| 出版信息 | 出版商: W.B. Saunders，出版周期: Bimonthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1974，原创研究文献占比: 0.00%，自引率:3.30%， Gold OA占比: 16.19% |
| 平均审稿周期 | 网友分享经验：较慢,6-12周 |
| 平均录用比例 | 网友分享经验：一般 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics
2024-9-1
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis
2024-8-1
Editorial Board
2024-6-1
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment
2024-6-1
Table of Contents
2024-6-1
Outside front cover
2024-6-1
Masthead
2024-6-1
Assessment of PSA responses and changes in the rate of tumor growth -rate with immune checkpoint inhibitors in US Veterans with prostate cancer
2024-5-1
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease
2024-5-1
Reno study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain
2024-3-1
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer
2024-2-1
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists
2024-2-1
PARP inhibitors in ovarian cancer
2024-2-1
Seminars in oncology 50th anniversary
2024-2-1
Table of Contents
2024-2-1
Editorial Board
2024-2-1
Masthead
2024-2-1
PARP inhibitors for prostate cancer
2024-2-1
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance
2024-2-1
Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer
2024-2-1
Outside front cover
2024-2-1
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data
2023-12-1
Primary adrenal insufficiency induced by immune checkpoint inhibitors: Biological, clinical, and radiological aspects
2023-12-1
Overcoming barriers to opioid-induced constipation management in cancer patients
2023-12-1
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis
2023-12-1
TOC
2023-12-1
outside front cover
2023-12-1
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety
2023-12-1
Editorial Board
2023-12-1
Masthead
2023-12-1
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics
2023-10-1
PARP inhibitors for prostate cancer
2023-9-25
Practice change: No benefit of extended lymphadenectomy at radical cystectomy in patients with muscle invasive bladder cancer
2023-6-1
outside front cover
2023-6-1
Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?
2023-6-1
NTRK fusion-positive cancer in nonagenarian patient. The importance of comprehensive geriatric assessment in older people for the inclusion in clinical trials
2023-6-1
TOC
2023-6-1
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients
2023-6-1
Acute liver failure secondary to malignant infiltration: A single center experience
2023-6-1
Efficacy of memantine in preventing neurocognitive dysfunction induced by radiation therapy in patients with brain metastases: A systematic review of clinical trials
2023-6-1
Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review
2023-6-1
Editorial Board
2023-6-1
Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents
2023-6-1
Masthead
2023-6-1
Outcomes with panobinostat in heavily pretreated multiple myeloma patients
2023-2-1
Non-pharmacologic interventions for improving cancer-related fatigue (CRF): A systematic review of systematic reviews and pooled meta-analysis
2023-2-1
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)
2023-2-1
Battling chronic myeloid leukemia in a resource-constrained country: A case of public-private partnerships
2023-2-1
Epidemiology and genetics of early onset colorectal cancer—African overview with a focus on Ethiopia
2023-2-1
TOC
2023-2-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远